ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,851.70
-0.15%
S&P ASX All Technology
3,077.90
0.70%
Brent Oil
82.295
-1.48%
US Dollar vs AUD
1.49835
-0.03%
Bitcoin
71,171.69
-0.39%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Neovacs (ALNEV)

  7. Neovacs (ALNEV) News

ALNEV

Neovacs (ALNEV)

Neovacs
Date:
Sort by:
 Showing the most relevant articles for your search:EU:ALNEV
DateTimeSourceHeadlineSymbolCompany
07/12/201903:45GlobeNewswire Inc.OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGSEU:ALNEVNeovacs
07/12/201903:45GlobeNewswire Inc.APPEL D’OFFRES EN VUE D’UN PLAN DE CONTINUATION OU DE CESSION DANS LE CADRE D’UNE PROCÉDURE DE REDRESSEMENT JUDICIAIRE...EU:ALNEVNeovacs
28/11/201905:00GlobeNewswire Inc.NEOVACS :EU:ALNEVNeovacs
14/11/201904:00GlobeNewswire Inc.NEOVACS REQUESTS A REORGANIZATION PROCEEDINGS OF THE COMPANYEU:ALNEVNeovacs
14/11/201904:00GlobeNewswire Inc.NÉOVACS SOLLICITE UNE PROCÉDURE DE REDRESSEMENT JUDICIAIREEU:ALNEVNeovacs
09/11/201906:05GlobeNewswire Inc.POINT SUR LA SITUATION FINANCIÈRE DE LA SOCIÉTÉ ET SUSPENSION DU COURS DE BOURSEEU:ALNEVNeovacs
31/10/201903:45GlobeNewswire Inc.MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2019EU:ALNEVNeovacs
03/10/201905:31GlobeNewswire Inc.NEOVACS ANNOUNCES ITS 2019 HALF-YEAR RESULTSEU:ALNEVNeovacs
03/10/201905:31GlobeNewswire Inc.NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019EU:ALNEVNeovacs
30/09/201916:30GlobeNewswire Inc.NÉOVACS ANNONCE LA NOMINATION DE VINCENT SERRA EN QUALITÉ DE DIRECTEUR GÉNÉRALEU:ALNEVNeovacs
30/09/201916:30GlobeNewswire Inc.NEOVACS ANNOUNCES APPOINTMENT OF VINCENT SERRA AS CHIEF EXECUTIVE OFFICEREU:ALNEVNeovacs
10/09/201901:45GlobeNewswire Inc.Neovacs : 2019 Financial CalendarEU:ALNEVNeovacs
10/09/201901:45GlobeNewswire Inc.Néovacs : Agenda financier 2019EU:ALNEVNeovacs
09/07/201915:30GlobeNewswire Inc.NEOVACS ANNOUNCES THAT THE POSITIVE RESULTS OF ITS PROOF OF CONCEPT IN ALLERGIES WITH IL-4 / IL-13 KINOID HAVE TRIGGERED THE ...EU:ALNEVNeovacs
09/07/201915:30GlobeNewswire Inc.NÉOVACS REÇOIT LE PREMIER VERSEMENT DE LA SUBVENTION ANR SUITE À LA PRÉSENTATION DES RÉSULTATS POSITIFS DE SA PREUVE DE ...EU:ALNEVNeovacs
27/06/201915:30GlobeNewswire Inc.NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENTIFIC ADVISOREU:ALNEVNeovacs
27/06/201915:30GlobeNewswire Inc.NÉOVACS ANNONCE LA NOMINATION DU Dr. VIRGINIA PASCUAL EN TANT QUE CONSEILLÈRE MÉDICALE ET SCIENTIFIQUEEU:ALNEVNeovacs
05/06/201915:30GlobeNewswire Inc.Neovacs to present the pre-clinical results of its IFNalpha Kinoid to treat type 1 diabetes - American Diabetes Association's...EU:ALNEVNeovacs
05/06/201915:30GlobeNewswire Inc.Néovacs présente les résultats précliniques de l'IFNalpha Kinoïde pour le traitement du diabète de type 1 - 79ème conf...EU:ALNEVNeovacs
04/06/201901:56GlobeNewswire Inc.Néovacs annonce avoir réuni son Assemblée Générale Mixte sur seconde convocation le mercredi 29 mai 2019EU:ALNEVNeovacs
23/05/201915:30GlobeNewswire Inc.NÉOVACS PROCÈDE AUX TIRAGES DE LA SECONDE TRANCHE PRÉVUE PAR SON PROGRAMME DE FINANCEMENT ET D’UNE TRANCHE ADDITIONNELLE...EU:ALNEVNeovacs
16/05/201915:30GlobeNewswire Inc.Neovacs to present the pre-clinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid to treat allergic Asthma...EU:ALNEVNeovacs
16/05/201915:30GlobeNewswire Inc.Néovacs présente les résultats précliniques de son candidat vaccin thérapeutique IL-4 / IL-13 Kinoïde pour le traitemen...EU:ALNEVNeovacs
01/05/201901:45GlobeNewswire Inc.Néovacs : mise à disposition du rapport financier annuel 2018 et du rapport sur le gouvernement d'entrepriseEU:ALNEVNeovacs
09/04/201915:30GlobeNewswire Inc.Neovacs announces the full results of its Phase IIb Clinical study of IFNalpha Kinoid in lupus - 13th International Lupus Con...EU:ALNEVNeovacs
09/04/201915:30GlobeNewswire Inc.Néovacs annonce les résultats complets de son étude clinique de phase IIb avec l'IFNalpha Kinoïde dans le lupus - 13ème ...EU:ALNEVNeovacs
06/04/201903:00GlobeNewswire Inc.Agenda financier 2019EU:ALNEVNeovacs
06/04/201903:00GlobeNewswire Inc.2019 Financial CalendarEU:ALNEVNeovacs
01/04/201916:30GlobeNewswire Inc.Néovacs annonce un accord avec Biosyn GmbH afin de diversifier son approvisionnement en Keyhole Limpet Hemocyanin (KLH)EU:ALNEVNeovacs
01/04/201916:30GlobeNewswire Inc.Neovacs announces an agreement with Biosyn GmbH to diversify its supply of Keyhole Limpet Hemocyanin (KLH)EU:ALNEVNeovacs
 Showing the most relevant articles for your search:EU:ALNEV

Your Recent History

COIN
ETHUSD
Ethereum
ASX
WBC
Westpac Banking
FX
EURAUD
Euro vs AUD
ASX
TLS
Telstra
NASDAQ
MSFT
Microsoft
ASX
CBA
Commonwealth Bank Of Aus...
ASX
XAO
Australian SE All Ordina...
FX
AUDJPY
AUD vs Yen
FX
AUDUSD
AUD vs US Dollar
ASX
WDC
Westfield
ASX
AMP
AMP
ASX
XFL
S&P ASX 50
ASX
NCM
Newcrest Mining
CCOM
SILVER
SILVER
ASX
FMG
Fortescue
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved